The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Mentored Research Award (MRA) Program
The HTRS MRA Program provides grants for fellows or junior attending/junior faculty pursuing careers in clinical, translational, or basic science research in hemostasis or thrombosis under the guidance of an experienced mentor or mentors. Since the Program’s inception in 2007, HTRS has awarded more than $9 million in grant support for 62 Mentored Research Award recipients.
The goals of the HTRS MRA Program are to:
- Increase the number of skilled physician-scientists and investigators in the U.S. and Canadian medical workforce dedicated to long-term research careers in classical hematology
- Support innovative research by pairing talented, promising young early-career physician-scientists and investigators with experienced mentors, many of whom are recognized leaders in clinical and/or basic science research in hemostasis and thrombosis
- Provide trainees and junior faculty in the U.S. or Canada an accessible “on-ramp” into either the NIH or CIHR research pipeline by funding initial research programs that can spark and support K-award applications (or equivalent)
- Upon completion of a project funded by the MRA Program, the recipient should be ready to apply for a larger-scale grant to expand their research such as a K08 or K23 from the National Institutes of Health (NIH) in the U.S. or the equivalent from another agency such as the Canadian Institutes of Health Research (CIHR)
Deadline for Pre-proposals: Aug. 14, 2023
- Eligible applicants must hold an MD, MD/PhD, PhD, DO, MBBS, or an equivalent medical degree.
- Only applicants and mentors employed by academic, non-commercial institutions are eligible. Applicants must declare their intent to pursue an academic research career in hemostasis or thrombosis (or an academic research career that will have a substantial component of, or overlap with, hemostasis and/or thrombosis).
- U.S. or Canadian citizenship is not required to apply; however, award recipients must agree to live and work in the U.S. or Canada for the tenure of their MRA-funded project. Non-U.S. citizen applicants with a J1 Visa waiver – even those in their first faculty positions – are encouraged to apply, as are those with an equivalent Canadian visa.
HTRS encourages applicants from historically excluded and underrepresented populations to apply, understanding that a diverse scientific workforce will, according to NIH research: foster scientific innovation, contribute to robust learning environments, improve the quality of the research, and advance the likelihood that underserved or health-disparate populations will benefit from this research.
This includes individuals from racial and ethnic groups who have been shown by the National Science Foundation to be underrepresented and/or historically excluded in health-related sciences on a national basis, as well as individuals with disabilities, students from low socioeconomic (SES) status backgrounds, individuals from disadvantaged backgrounds, and women.
MRAs of $162,000 USD will be distributed by HTRS to the successful applicant’s institution in three payments: 1. The first payment of $81,000 USD (50% of the award) will be issued after full execution of the legal grant agreement contract between HTRS, the awardee, and the recipient institution. 2. The second payment of $64,800 USD (40% of the award) will be issued after HTRS approves a formal 12- month progress report describing research conducted during the first year of the project period. 3. The third payment of $16,200 USD (10% of the award) is contingent upon approval by HTRS of a final, 24-month report upon completion of the project period.